We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Neurological Disorder Linked to Genetic Mutations

By LabMedica International staff writers
Posted on 04 Jan 2012
Print article
A gene has been detected that is linked to epilepsy in babies and movement disorders in older children.

The gene has been associated with the rare childhood neurological disorder known as paroxysmal kinesigenic dyskinesia with infantile convulsions or PKD/IC.

A large international team led by scientists at the University of California, San Francisco (UCSF; USA) studied ways that could help to improve the diagnosis of PKD/IC and may also help to explain other movement disorders, such as Parkinson's disease. The team has identified a perplexing gene in the brain called proline-rich transmembrane protein 2 (PRRT2). No knowledge exists about the function or ability of this gene, which bears little resemblance to anything else in the human genome.

The scientists conducted the study on a cohort of 103 families, which included one or more members with the PKD/IC manifestation. The investigators identified mutations in the PRRT2 gene that is present in the brain and spinal cord, during genetic testing of the families. The mutation causes the proteins that the PRRT2 gene encodes to shorten or to completely disappear from the individual's brain and spinal cord. According to the investigative team, the neurological symptoms may be caused due to a loss of neuronal regulation, meaning that when the genetic mutations cause the gene products to disappear, the nerve cells, which normally appear in those locations, may become overly excited, firing signals too frequently or strongly, which leads to the involuntary movements.

Louis Ptacek, MD, the senior author of the study, said, "This is both exciting and a little bit scary. Understanding the underlying biology of this disease is absolutely going to help us understand movement disorders in general." PKD/IC is a rare disorder in infants with epileptic seizures, affecting approximately one in every 100,000 children in the US, according to Prof. Ptacek's estimation. It commonly disappears within a year or two but often reemerges later in childhood as a movement disorder, which is characterized by sudden, startling, involuntary jerks when the children start moving. In some children just the thought of moving will cause them to jerk involuntarily. The disease is classified as idiopathic, which, is basically just another way of saying the cause is unknown. The study was published in the January 2012 issue of Cell Reports.

UCSF


Related Links:
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.